View the Published
Tutivia™ Validation Study
How to Order
Form
Who We Are
Leadership
Careers
Investors
Media
News
Events
Investors
About Verici Dx
Regulatory News
Results, Events, & Presentations
Annual & Interim Reports
Financial Calendar
Shareholder Centre
Corporate Governance
FAQs
AIM Rule 26
Insights
Contact Us
Products
Tutivia™
Clarava™
Protega™
How to Order
Services
Technology
Background
RNA Signatures
Sequencing
Professionals
Clinical Data
Validation Study Results
Importance of a Risk Score
CLIA Lab
Patients
Patient Journey
Partners
AKF
ASN
AST
ASTS
KDIGO
NKF
Educational Center
Patient Journey
Publications
Video Resources
ATC Presentation 2024
Downloadable Documents
Products
Tutivia™
Clarava™
Protega™
How to Order
Services
Technology
Background
RNA Signatures
Sequencing
Professionals
Clinical Data
Validation Study Results
Importance of a Risk Score
CLIA Lab
Patients
Patient Journey
Partners
AKF
ASN
AST
ASTS
KDIGO
NKF
Educational Center
Patient Journey
Publications
Video Resources
ATC Presentation 2024
Downloadable Documents
How to Order
Form
Who We Are
Leadership
Careers
Investors
Media
News
Events
Investors
About Verici Dx
Regulatory News
Results, Events, & Presentations
Annual & Interim Reports
Financial Calendar
Shareholder Centre
Corporate Governance
FAQs
AIM Rule 26
Insights
Contact Us
News
TR-1: Standard form for notification of major holdings
March 23, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 21, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 18, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 16, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 15, 2022
Notification of major holdings
Keep Reading
Close of Subscription and Fundraise Update
March 11, 2022
The Subscription has now closed and the Fundraise has successfully concluded, save for Admission.
Keep Reading
Fundraise - Successful Placing
March 4, 2022
Verici Dx is pleased to announce the successful completion of the Placing.
Keep Reading
Close of Accelerated Bookbuild
March 4, 2022
Further to the announcement made at 7.10 a.m. today, the Placing has now closed and the Bookbuild has been successfully concluded.
Keep Reading
Proposed Fundraise to raise not less than £10.0 million (approximately $13.3 million)
March 4, 2022
Verici Dx announces its intention to conduct a fundraise through the non pre-emptive issue of at least 28,571,429 new ordinary shares
Keep Reading
Successful completion of analytical validation for Clarava™ and Tuteva™
February 15, 2022
Lead products meet comprehensive requirements at CLIA-certified laboratory, representing an important milestone towards commercialisation
Keep Reading
« Previous
1
2
3
4
5
6
…
8
Next »
Archived News
close
chevron-down
bars
cross
menu
chevron-down
